-
records of medication use without ADRs. The vaccine data is more recent and is built through two global networks. Genotyping data includes both array-based platforms (Illumina Global Screening Array) and
-
includes both array-based platforms (Illumina Global Screening Array) and cutting-edge sequencing technologies, such as exome and short- and long-read whole-genome sequencing. The candidate will also benefit
-
to 12,493 detailed ADR reports and 116,635 records of medication use without ADRs. The vaccine data is more recent and is built through two global networks. Genotyping data includes both array-based
-
networks. Genotyping data includes both array-based platforms (Illumina Global Screening Array) and cutting-edge sequencing technologies, such as exome and short- and long-read whole-genome sequencing